Results 111 to 120 of about 2,385 (197)

Cangrelor bridging strategy for liver damage after mechanical chest compression

Anatolian Journal of Cardiology, 2019
Alberto Francesco Cereda, Nuccia Morici, Paolo Aseni, Osvaldo Chiara   +3 more
doaj   +1 more source

Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis. [PDF]

Crit Care
Hendrianus H, Jeong YH, Lee SY, Cho JH, Jo J, Gorog DA, Kubica J, Tantry US, Gurbel PA, Kim SW.   +9 more
europepmc   +1 more source

Use of Cangrelor in Türkiye: A Multicenter Real-Life Study. [PDF]

J Clin Med
Altay S, Gül İ, Aytemiz F, Kibar M, Süleymaoğlu C, Fedai H, Çatakoğlu AB, Çetin Ş, Yöndem S, Yazıcıoğlu MV, Köprülü D, Çetin M, Yildiz SS, Çakal B, Yayla Ç, Korkmaz S.   +15 more
europepmc   +1 more source

Thrombocytosis-associated ticagrelor non-responder status after ECMO-supported primary PCI in STEMI. [PDF]

J Cardiol Cases
Strohhofer C, Alber H, Dörler J.
europepmc   +1 more source

The Impact of Cangrelor in the UK for the Treatment of STEMI Patients with Gastric Absorption Issues Undergoing Percutaneous Coronary Intervention. [PDF]

J Clin Med
Modi B, Cain R, Stork R, Tarpey G, Colucciello A, Olivier D, Barwood C, Wright W, McAtamney R.   +8 more
europepmc   +1 more source

Impact of intraprocedural antiplatelet therapy on stent patency and safety after emergent intracranial stenting in acute ischaemic stroke: insights from the RESISTANT registry. [PDF]

Eur Stroke J
Diana F, Hassan AE, Ortega-Gutierrez S, Miller S, Rodriguez-Calienes A, Olive Gadea M, Kaesmacher J, Mujanovic A, Geyik S, Senadim S, Piano M, Cervo A, Salcuni A, Moreu M, López-Frías A, Zapata Arriaza E, de Albóniga-Chindurza A, Bergui M, Molinaro S, Sousa JA, Sargento-Freitas J, Gomes F, Alexandre A, Pedicelli A, Machi P, Hofmeister J, Scarcia L, Kalsoum E, Amorim J, Meira T, Renieri L, Capasso F, Romano DG, Barcena E, Seoane D, Abdalkader M, Klein P, Nguyen TN, Perry C, Fragata I, Yavagal DR, Charles JH, Rodríguez J, Vega P, Özdemir AÖ, Uysal Z, Smajda S, Al Salman S, Khalife J, Jovin T, Biraschi F, Ricchetti F, Castro P, Albuquerque L, Siddiqui AH, Jaikumar V, Navia P, Ntoulias N, Psychogios M, Velo M, Zamarro J, de Paco G, Ashouri Y, AlMajali M, Arenillas JF, Sierra A, Romoli M, Marto JP, Yaghi S, Peschillo S, Ribo M, Tomasello A, Requena M.   +72 more
europepmc   +1 more source

The role of cangrelor in acute and high-risk PCI settings. [PDF]

Eur Heart J Cardiovasc Pharmacother
Zeymer U, Geisler T, Westermann D, Huber K.   +3 more
europepmc   +1 more source

Endovascular management of tandem occlusions: current evidence and future directions. [PDF]

J Neurointerv Surg
Krothapalli N, Heit JJ, de Havenon A, Singhal AB, Sussman E, Hasan D, Mac Grory B.   +6 more
europepmc   +1 more source

Safety and efficacy of Cangrelor versus GPIIb/IIIa inhibitors as adjunctive therapy in endovascular treatment of acute ischemic stroke: a systematic review and meta-analysis. [PDF]

J Thromb Thrombolysis
Ellebedy M, Mohamed RG, Lamie MI, Abbas OF, Hegazi A, Kashbour M.   +5 more
europepmc   +1 more source

Comparative Effects of P2Y12 Inhibitors on Thrombus Biology and Inflammatory Responses in Atherothrombotic Cardiovascular Disease: A Systematic Review of Randomized Controlled Trials. [PDF]

Cureus
Ullah N, Ali M, Dad Khan I, Khan M, Jamil H, Anthony N.   +5 more
europepmc   +1 more source